Shalhout SZ, Bloom R, Drake L, Miller DM. Evaluation of the fragility of pivotal trials used to support US Food and Drug Administration approval for plaque psoriasis. J Am Acad Dermatol. 2021 Feb;84(2):354-360. doi: 10.1016/j.jaad.2020.04.057. Epub 2020 Apr 19. PMID: 32320767.
Marks DH, Penzi LR, Ibler E, Manatis-Lornell A, Hagigeorges D, Yasuda M, Drake LA, Senna MM. The Medical and Psychosocial Associations of Alopecia: Recognizing Hair Loss as More Than a Cosmetic Concern. Am J Clin Dermatol. 2019 Apr;20(2):195-200.
Rossi AM, Wilson B, Hibler BP, Drake LA. Nonphysician Practice of Cosmetic Dermatology: A Patient and Physician Perspective of Outcomes and Adverse Events. Dermatol Surg. 2019 Apr;45(4):588-597. PMCID: PMC6450566 [Available on 2020-04-01]
Rajabi F, Drake LA, Senna MM, Rezaei N. Alopecia areata: a review of disease pathogenesis. Br J Dermatol. 2018;179:1033-48. Review.
Rand S, DiGiovanna JJ, Maibach HI, Halder R, Wilkin JK, Chanco Turner ML, Drake LA, Voorhees JJ. CLARENCE CARNOT EVANS II, MD: A Statesman for Dermatology. J Am Acad Dermatol. 2018;78(3):e77-8.
Drake LA. Dr. Wilma Fowler Bergfeld: A Woman of Substance, Role Model, and Founder of the Women's Dermatologic Society. Int J Womens Dermatol. 2017 Feb 16;3(1 Suppl):S42-S48. No abstract available. PMCID: PMC5419041
Roberts WE, Sadick NS, Bergfeld WF, Paller AS, Callender VD, Drake LA; WDS Industry Visioning Work Group. Physician-Industry Collaboration: Organizational Considerations for the Future of Innovation and Growth in Dermatology. Int J Womens Dermatol. 2017 Dec 1;3(4):239-243. PMCID: PMC5715232
Lin RL, Garibyan L, Kimball AB, Drake LA. Systemic causes of hair loss. Ann Med. 2016 Sep;48(6):393-402.
Roberts WE, Sadick NS, Bergfeld WF, Paller AS, Callender VD, Drake LA, WDS Industry Visioning Work Group. Physician-Industry Collaboration: Organizational Considerations for the Future of Innovation and Growth in Dermatology. Int J Women's Derm., Vol. 2, Issue 2, p60–61. PMCID: PMC5412093
Bergfeld WF, Drake LA. The Women's Dermatology Society: Physicians, Leaders, Mentors. Int J Women's Derm, Vol. 1, Issue 1, p2–3.
Drake LA. Dr. Wilma Fowler Bergfeld: A woman of substance, role model, and founder of the Women's Dermatologic Society. Int J Women's Derm, Vol. 1, Issue 3, p116–122. PMCID: PMC5418874
Olsen EA, Whiting DA, Savin R, Rodgers A, Johnson-Levonas AO, Round E, Rotonda J, Kaufman KD; Male Pattern Hair Loss Study Group. Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo. J Am Acad Dermatol. 2012 Sep;67(3):379-86.
Leyden J, Bergfeld W, Drake L, Dunlap F, Goldman MP, Gottlieb AB, Heffernan MP, Hickman JG, Hordinsky M, Jarrett M, Kang S, Lucky A, Peck G, Phillips T, Rapaport M, Roberts J, Savin R, Sawaya ME, Shalita A, Shavin J, Shaw JC, Stein L, Stewart D, Strauss J, Swinehart J, Swinyer L, Thiboutot D, Washenik K, Weinstein G, Whiting D, Pappas F, Sanchez M, Terranella L, Waldstreicher J. A systemic type i 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. J Am Acad Dermatol 2004; 50(3):443-447.
Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, Powell F; National Rosacea Society Expert Committee. Standard grading system for rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004; 50(6):907-12.
Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Paller AS, Stevens SR, Whitaker-Worth DL, Tong KB. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis. J Am Acad Dermatol 2003; 48(4):553-63.
Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Stevens SR, Whitaker-Worth DL, Tong KB. Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczema. Pharmacoeconomics 2003; 21(12):875-883.
Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Stevens SR, Whitaker-Worth DL, Cheng JW, Tong KB. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002; 46(3):361-370.
Naugle C, Drake LA. 8% glycolic and 8% lactic acid. In: Moy R, Luftman D, Kakita LS, editors. Glycolic acid peels. New York, Basel: Marcel Dekker; 2002. p. 193-206.
Wilkin J, Dahl M, Detmar M, Drake LA, Feinstein A, Odom R, Powell F. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46 (4): 584-587.
Arenas R, Drake L, De Doncker P, Ginter G, Yaniv R. Itraconazole Pulse Therapy for Onychomycosis: A Meta-Analysis of Pooled Safety Data. Intl J Dermatol, Submitted, 2000
Drake LA, Prendergast M, Maher R, Breneman D, Cooper K, Yoichi S, Beusterien K, Lawrence I. The impact of tacrolimus ointment on health-related quality-of-life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001; 44(1 Suppl):S65-72.
Ellis C, Drake L, Prendergast M, Abramovits W, Boguniewicz M, Daniel C, Lebwohl M, Stevens S, Whitaker-Worth D, Tong K. Third-party payer cost of atopic dermatitis and eczema in the United States. J Invest Dermatol 2001; 117(2):852
Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Stevens SR, Whitaker-Worth DL, Cheng JW, Tong KB. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol. 2002 Mar; 46(3):361-70.
Lebwohl M, Drake LA, Menter A, Koo J, Gottlieb A, Zanolli M, Young M, McClelland P. Consensus conference: Acitretin in combination with UVB or PUVA in the treatment of psoriasis. J Am Acad Dermatol 2001 45 (4): 544-553.
Smith S, Kollias N, Gillies R, Muccini J, Phillips S, Stiller M, Hong J, Drake L. Improvement of Psoriatic Plaques Treated With Long-term Calcipotriol is Better Assessed Using Polarized Photography and Spectroscopy. Submitted, 2001
Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarrat MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker D, Rafal ES, Savin RP, Roth HL, Chang LK, Baginski D, Kempers S, McLane J, Eberhardt D, Leach EE, Bryce G, Hong J. Safety of a new micronized formulation of isotetretionoin in patients with severe recalcitrant nodular acne: a randomized trial comparing micronized isotetretionoin with standard isotetretionoin. J Am Acad Dermatol 2001; 45(2):196-207.
Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarrat MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker D, Rafal ES, Savin RP, Roth HL, Chang LK, Baginski D, Kempers S, McLane J, Eberhardt D, Leach EE, Bryce G, Hong J. A randmized trial of the efficacy of a new micronized formualtion versus a standard formulation of isotetretionoin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol 2001; 45(2):187-195.
Wyatt EL, Sutter SH, Drake LA. Dermatological pharmacology. In: Hardman JG, Limbird LE. Editors. Goodman & Gilman’s the pharmacological basis of therapeutics. New York: McGraw-Hill; 2001. p. 1795-1818.
Shear N, Drake LA, Gupta AK, Lambert J. The implications and management of drug interactions with itraconazole, fluconazole and terbinafine. Dermatol 2000; 201(3):196-203.
95 publications prior to the year 2000.
